Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

331.00p
   
  • Change Today:
      10.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 229,494
  • Market Cap: £331.00m
  • RiskGrade: 125

Deal with Barclays    Trade now with Barclays Stockbrokers

Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output

By Frank Prenesti

Date: Tuesday 18 May 2021

LONDON (ShareCast) - (Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.
Oxford Biomedica, which has an 18-month supply deal with AstraZeneca to make its AZD1222 vaccine, lifted forecasts for expected cumulative revenues to more than £100m by end-2021 from more than £50m.

As a result, Oxford Biomedica said it expected 'significant growth' in annual operating earnings for the year to end-December.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 331.00p
Change Today 10.50p
% Change 3.28 %
52 Week High 470.00
52 Week Low 166.80
Volume 229,494
Shares Issued 100.00m
Market Cap £331.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.26% below the market average27.26% below the market average27.26% below the market average27.26% below the market average27.26% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
1.33% below the market average1.33% below the market average1.33% below the market average1.33% below the market average1.33% below the market average
37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average
Income Not Available
Growth
52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
16:41 19,813 @ 331.00p
16:35 66,721 @ 331.00p
16:35 61 @ 331.00p
16:35 87 @ 331.00p
16:35 138 @ 331.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page